(Q34861058)

4 August 2017

title

Peginterferon with or without ribavirin has minimal effect on quality of life, behavioral/emotional, and cognitive outcomes in children (English)

1 reference

4 August 2017

1 reference

1 reference

14

Bruce Barton

1 reference

4 August 2017

6

Jean P Molleston

1 reference

4 August 2017

James R Rodrigue

1

1 reference

4 August 2017

William Balistreri

2

1 reference

4 August 2017

Barbara Haber

3

1 reference

4 August 2017

Maureen M Jonas

4

1 reference

4 August 2017

Parvathi Mohan

5

1 reference

4 August 2017

Karen F Murray

7

1 reference

4 August 2017

Michael R Narkewicz

8

1 reference

4 August 2017

Philip Rosenthal

9

1 reference

4 August 2017

Lesley J Smith

10

1 reference

4 August 2017

Steven J Lobritto

11

1 reference

4 August 2017

Kathleen B Schwarz

12

1 reference

4 August 2017

Patricia R Robuck

13

1 reference

4 August 2017

Regino P González-Peralta

15

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

4 August 2017

1 reference

4 August 2017

volume

53

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

1468-1475

1 reference

Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C.

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082614

Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional Outcomes

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082614

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082614

Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082614

Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082614

The effects of HCV infection and management on health-related quality of life

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082614

A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082614

Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082614

Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082614

Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082614

Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082614

Side effects of alpha-interferon therapy and impact on health-related quality of life in children with chronic viral hepatitis.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3082614

The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period

8 July 2018

1 reference

Three broad modalities in the natural history of vertically acquired hepatitis C virus infection

21 January 2018

1 reference

Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection

21 January 2018

1 reference

The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.

21 January 2018

1 reference

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics

21 January 2018

1 reference

Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection

21 January 2018

1 reference

Prevalence of fibromyalgia, anxiety and depression in chronic hepatitis C virus infection: relationship to RT-PCR status and mode of acquisition

21 January 2018

1 reference

Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): results from a prospective study.

21 January 2018

1 reference

Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study

21 January 2018

1 reference

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.

21 January 2018

1 reference

Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C.

21 January 2018

1 reference

Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C.

21 January 2018

1 reference

Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21351116

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/HEP.24248

1 reference

4 August 2017

1 reference

4 August 2017

1 reference